fda_483 · inspection_citation · high

Aurobindo Pharma Ltd. Unit-XII -- FDA 483: 8 observations (2025-09-05)

Event date
2025-09-05 00:00:00Z
Observed
2026-07-12 22:31:42Z
Source ID
3004446312-2025-09-05-189107
Payload hash
589e202dbc28f0c5e9e89d3b

Summary

Observation 1: Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed, or did not include adequate validation of the as...

Informational only. Not legal, financial, or medical advice.